| The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a
|
| Author(s): Hanne van Ballegooijen, Karin van der Hiele, Christian Enzinger, Gert de Voer, Leo H. Visser, on behalf of the CONFIDENCE Study Group |
| Affiliations(s): IQVIA Netherlands, Real World Evidence, Netherlands
b
Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, Netherlands
c
Medical University of Graz, Graz, Austria
d
Merck BV, Schiphol-Rijk, The Netherlands, an affiliate of Merck KGaA, Germany
e
St Elisabeth Tweesteden Hospital, Tilburg, the Netherlands |
Publication(s): eNeurologicalSci,
Volume 28,
2022,
100409,
ISSN 2405-6502,
https://doi.org/10.1016/j.ensci.2022.100409.
(https://www.sciencedirect.com/science/article/pii/S2405650222000181)
|
| Document Type(s): Article, |
| Countries: Austria, Belgium, Netherlands , Slovakia, |
| Click here for the abstract |
C:
Y: |
Drug safety, Drug Utlization Study, Neurological disorders,
2022 |
|
L:
A: |
English
Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Prospective study, |
|
 |
| |
| |
| Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China |
| Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
|
| Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium.
2R&D China, AstraZeneca R&D, Shanghai, China.
3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo.
#Contributed equally. |
Publication(s): BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
|
| Document Type(s): Article, |
| Countries: Belgium, China, |
| Click here for the abstract |
C:
Y: |
Health economics, Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| A novel decision model to predict the impact of weight management interventions: The Core Obesity Model. |
| Author(s): Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4
|
| Affiliations(s): 1Novo Nordisk A/S Søborg Denmark.
2IQVIA Zaventem Belgium.
3IQVIA Basel Switzerland.
4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK. |
Publication(s): Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495
|
| Document Type(s): Article, |
| Countries: Belgium, Switzerland, |
| Click here for the abstract |
C:
Y: |
Health economics, Obesity,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| Office-based Approach to Urinary Tract Infections in 50 000 Patients: Results From the REWIND Study
|
| Author(s): Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi JC, Van Bruwaene S
|
| Affiliations(s): Cai T: Department of Urology, Santa Chiara Regional Hospital, Trento, Italy. Cipelli: Obs Studies Consultat, IQVIA, RWS, Milan, Italy.
|
| Publication(s): |
| Document Type(s): Article, |
| Countries: Belgium, Brazil, Italy, Russian Federation, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2021 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Retrospective database analysis, |
|
|
| |
| |
| Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety. |
| Author(s): Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-Gabarró 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13 |
| Affiliations(s): 1Real World Solutions, IQVIA, London, UK.
2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK.
3Data & Computational Sciences, GSK, London, UK.
4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA.
5Gillian Hall Epidemiology Ltd, London, UK.
6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA.
7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
8Bayer AG, Berlin, Germany.
9PRA Health Sciences, Raleigh, North Carolina, USA.
10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.
12The Procter & Gamble Company, Cincinnati, Ohio, USA.
13UCB Pharma, Anderlecht, Belgium. |
Publication(s): Pharmacoepidemiol Drug Saf
. 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13.
|
| Document Type(s): Article, |
| Countries: Belgium, Germany, UK, USA, |
| Click here for the abstract |
C:
Y: |
Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods,
2021 |
|
L:
A: |
English
Patient questionnaire, Review, |
|
|
| |
| |
| The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results |
| Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8 |
| Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands |
Publication(s): European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
|
| Document Type(s): Poster, |
| Countries: Belgium, France, Germany, Italy, UK, |
C:
Y: |
Clinical practice, Public Health,
2020 |
|
L:
A: |
English
Population Based Study, Public Health, Retrospective database analysis, |
|
|
| |
| |
| Predictors of iron‑deficiency anemia in primary care older adults: a real‑world European multi‑country longitudinal study |
| Author(s): Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F |
| Affiliations(s): Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico “A. Gemelliâ€, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy |
Publication(s): Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
|
| Document Type(s): Article, |
| Countries: Belgium, Germany, Italy, Spain, |
| Click here for the abstract |
C:
Y: |
Hematology,
2020 |
|
L:
A: |
English
Epidemiological study, Retrospective database analysis, |
|
|
| |
| |
| External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions |
| Author(s): Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4 |
| Affiliations(s): 1Novo Nordisk A/S, Søborg, Denmark. snlb@novonordisk.com.
2Novo Nordisk A/S, Søborg, Denmark.
3IQVIA, Zaventem, Belgium.
4Health Economics and Outcomes Research Ltd, Cardiff, UK.
5IQVIA, Basel, Switzerland. |
Publication(s): Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30
|
| Document Type(s): Article, |
| Countries: Belgium, Denmark, Switzerland, UK, |
| Click here for the abstract |
C:
Y: |
Health economics, Obesity,
2020 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data. |
| Author(s): Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K |
| Affiliations(s): IQVIA, Eli Lilly |
Publication(s): Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
|
| Document Type(s): Article, |
| Countries: Belgium, Canada, France, Germany, Italy, Netherlands , |
| Click here for the abstract |
C:
Y: |
Diabetes,
2019 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe |
| Author(s): Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U |
| Affiliations(s): Fife: Janssen Research and Development, LLC
Waller: Adephi Real World
Kaplan: Teva Pharmaceutical Indusries Ltd.
Hu: Janssen Global Services
Phillips: IQVIA
Oliveria, IQVIA
Richarz: Janssen Research and Development, LLC |
Publication(s): Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
|
| Document Type(s): Article, |
| Countries: Belgium, France, Germany, Spain, UK, |
| Click here for the abstract |
C:
Y: |
Drug safety, Drug Utlization Study,
2019 |
|
L:
A: |
English
Population Based Study, Retrospective database analysis, |
|
|
| |
| |
 1 of 15 
|
